NCT00768820View on ClinicalTrials.gov

The Psychiatric and Cognitive Phenotypes in Velocardiofacial Syndrome

PHASE4RecruitingINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

May 31, 2001

Primary Completion Date

August 31, 2024

Study Completion Date

August 31, 2024

Conditions
Velocardiofacial SyndromeWilliams SyndromeFragile X Syndrome
Interventions
DRUG

methylphenidate, fluoxetin, risperidone

first cognitive evaluation without methylphenidate,second cognitive evaluation with methylphenidate

Trial Locations (1)

49202

RECRUITING

Schneider Children's Mediac Center of Israel, Petah Tikva

All Listed Sponsors
lead

The Chaim Sheba Medical Center

OTHER